Literature DB >> 26896095

NCI-MATCH Trial Draws Strong Interest.

Janet Colwell.   

Abstract

After 800 cancer patients enrolled during the first 3 months of the NCI-MATCH trial, organizers have extended a temporary halt in enrollment to gear up for the next phase. The basket study, which matches patients to approved or experimental drugs based on specific genetic mutations in their tumors, is expected to resume in April or May. ©2016 American Association for Cancer Research.

Entities:  

Mesh：

Year:  2016        PMID： 26896095     DOI： 10.1158/2159-8290.CD-NB2016-018

Source DB:  PubMed          Journal:  Cancer Discov        ISSN： 2159-8274            Impact factor:   39.397


  11 in total

1.  Going into BATTLE: umbrella and basket clinical trials to accelerate the study of biomarker-based therapies.

Authors:  Sawsan Rashdan; David E Gerber
Journal:  Ann Transl Med       Date:  2016-12

2.  The Drug Rediscovery protocol facilitates the expanded use of existing anticancer drugs.

Authors:  D L van der Velden; L R Hoes; H van der Wijngaart; J M van Berge Henegouwen; E van Werkhoven; P Roepman; R L Schilsky; W W J de Leng; A D R Huitema; B Nuijen; P M Nederlof; C M L van Herpen; D J A de Groot; L A Devriese; A Hoeben; M J A de Jonge; M Chalabi; E F Smit; A J de Langen; N Mehra; M Labots; E Kapiteijn; S Sleijfer; E Cuppen; H M W Verheul; H Gelderblom; E E Voest
Journal:  Nature       Date:  2019-09-30       Impact factor: 49.962

3.  Learning to Personalize from Practice: A Real World Evidence Approach of Care Plan Personalization based on Differential Patient Behavioral Responses in Care Management Records.

Authors:  Pei-Yun S Hsueh; Subhro Das; Chandramouli Maduri; Karie Kelly
Journal:  AMIA Annu Symp Proc       Date:  2018-12-05

Review 4.  Future Clinical Trials: Genetically Driven Trials.

Authors:  Igor Astsaturov
Journal:  Surg Oncol Clin N Am       Date:  2017-08-18       Impact factor: 3.495

Review 5.  Genomic sequencing and precision medicine in head and neck cancers.

Authors:  R C Hoesli; M L Ludwig; N L Michmerhuizen; A J Rosko; M E Spector; J C Brenner; A C Birkeland
Journal:  Eur J Surg Oncol       Date:  2016-12-15       Impact factor: 4.424

6.  Routine genetic testing of lung cancer specimens derived from surgery, bronchoscopy and fluid aspiration by next generation sequencing.

Authors:  Gou Yamamoto; Mari Kikuchi; Shiho Kobayashi; Yoshiko Arai; Kenji Fujiyoshi; Tomokazu Wakatsuki; Miho Kakuta; Yuki Yamane; Yoshihito Iijima; Hideaki Mizutani; Yuki Nakajima; Junko Sudo; Hiroyasu Kinoshita; Futoshi Kurimoto; Hirohiko Akiyama; Hidetaka Uramoto; Hiroshi Sakai; Yoshito Akagi; Kiwamu Akagi
Journal:  Int J Oncol       Date:  2017-03-27       Impact factor: 5.650

7.  Participant Attitudes Toward an Intensive Trial of Multiple Biopsies, Multidimensional Molecular Analysis, and Reporting of Results in Metastatic Triple-Negative Breast Cancer.

Authors:  Nicole M Kuderer; Kimberly A Burton; Sibel Blau; Francis Senecal; Vijayakrishna K Gadi; Stephanie Parker; Elisabeth Mahen; David Veenstra; Josh J Carlson; Gary H Lyman; C Anthony Blau
Journal:  JCO Precis Oncol       Date:  2017-08-16

8.  Precision oncology in the age of integrative genomics.

Authors:  Chandan Kumar-Sinha; Arul M Chinnaiyan
Journal:  Nat Biotechnol       Date:  2018-01-10       Impact factor: 54.908

9.  Tumor molecular profiling of NSCLC patients using next generation sequencing.

Authors:  Nikolaos Tsoulos; Eirini Papadopoulou; Vasiliki Metaxa-Mariatou; Georgios Tsaousis; Chrisoula Efstathiadou; Georgia Tounta; Aikaterini Scapeti; Eugenia Bourkoula; Pavlos Zarogoulidis; George Pentheroudakis; Stylianos Kakolyris; Ioannis Boukovinas; Pavlos Papakotoulas; Elias Athanasiadis; Theofanis Floros; Anna Koumarianou; Vasileios Barbounis; Anca Dinischiotu; George Nasioulas
Journal:  Oncol Rep       Date:  2017-10-23       Impact factor: 3.906

Review 10.  Inhibition of the fibroblast growth factor receptor (FGFR) pathway: the current landscape and barriers to clinical application.

Authors:  Young Kwang Chae; Keerthi Ranganath; Peter S Hammerman; Christos Vaklavas; Nisha Mohindra; Aparna Kalyan; Maria Matsangou; Ricardo Costa; Benedito Carneiro; Victoria M Villaflor; Massimo Cristofanilli; Francis J Giles
Journal:  Oncotarget       Date:  2017-02-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.